Chronic Myelogenous Leukemia, BCR-ABL Positive
2 clinical trials · Condition
◉ Watch Chronic Myelogenous Leukemia, BCR-ABL Positive
| Record | Firm | Date |
|---|---|---|
| Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment (NCT04883125) | Mansoura University | 2018-01-01 |
| OPTIM DASATINIB (Optimized Tyrosine Kinase Inhibitors Monotherapy) (NCT01916785) | Versailles Hospital | 2009-05-01 |
Track Chronic Myelogenous Leukemia, BCR-ABL Positive automatically
Every clearance here is in the API, with alerts when new ones post.